110 related articles for article (PubMed ID: 8397713)
1. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes.
Shehadeh NN; LaRosa F; Lafferty KJ
J Autoimmun; 1993 Jun; 6(3):291-300. PubMed ID: 8397713
[TBL] [Abstract][Full Text] [Related]
2. Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development.
Mori Y; Kodaka T; Kato T; Kanagawa EM; Kanagawa O
Int Immunol; 2009 Nov; 21(11):1291-9. PubMed ID: 19778991
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of a TH1 cytokine profile in the late phase of NOD insulitis.
Pilström B; Björk L; Böhme J
Cytokine; 1995 Nov; 7(8):806-14. PubMed ID: 8664448
[TBL] [Abstract][Full Text] [Related]
4. Islet regeneration during the reversal of autoimmune diabetes in NOD mice.
Kodama S; Kühtreiber W; Fujimura S; Dale EA; Faustman DL
Science; 2003 Nov; 302(5648):1223-7. PubMed ID: 14615542
[TBL] [Abstract][Full Text] [Related]
5. [Liposome and complete Freund's adjuvant for the prevention of insulitis in non-obese diabetic mice].
Su H; Jiang TJ; Zhou ZG
Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):32-4. PubMed ID: 12575229
[TBL] [Abstract][Full Text] [Related]
6. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
[TBL] [Abstract][Full Text] [Related]
7. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
Augstein P; Bahr J; Wachlin G; Heinke P; Berg S; Salzsieder E; Harrison LC
J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O
J Autoimmun; 1996 Oct; 9(5):645-51. PubMed ID: 8933280
[TBL] [Abstract][Full Text] [Related]
9. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
Qu P; Ji RC; Shimoda H; Miura M; Kato S
Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
[TBL] [Abstract][Full Text] [Related]
10. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
11. [Study on the prevention of insulitis and diabetes by complete Freund's adjuvant in NOD female mice].
Yang Z; Wu H; Zhou Z; Liao EY; Yang W
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):411-4. PubMed ID: 12080669
[TBL] [Abstract][Full Text] [Related]
12. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
Chang Y; Prud'homme GJ
J Gene Med; 1999; 1(6):415-23. PubMed ID: 10753067
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
[TBL] [Abstract][Full Text] [Related]
15. Immunization of diabetes-prone or non-diabetes-prone mice with GAD65 does not induce diabetes or islet cell pathology.
Plesner A; Worsaae A; Dyrberg T; Gotfredsen C; Michelsen BK; Petersen JS
J Autoimmun; 1998 Aug; 11(4):335-41. PubMed ID: 9776711
[TBL] [Abstract][Full Text] [Related]
16. Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes.
Lee IF; Qin H; Priatel JJ; Tan R
Eur J Immunol; 2008 Jan; 38(1):82-9. PubMed ID: 18085661
[TBL] [Abstract][Full Text] [Related]
17. Prevention of recurrence of insulin-dependent diabetes mellitus in islet cell-transplanted diabetic NOD mice using adjuvant therapy.
Lakey JR; Wang T; Warnock GL; Singh B; Rajotte RV
Transplant Proc; 1992 Dec; 24(6):2848. PubMed ID: 1465969
[No Abstract] [Full Text] [Related]
18. E expression is needed on both bone marrow derived cells and thymic epithelium to increase IL-4 production and achieve protection in NOD bone marrow chimeras.
Brenden N; Rietz C; Böhme J
Cytokine; 1999 Oct; 11(10):766-72. PubMed ID: 10525315
[TBL] [Abstract][Full Text] [Related]
19. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
Ablamunits V; Elias D; Reshef T; Cohen IR
J Autoimmun; 1998 Feb; 11(1):73-81. PubMed ID: 9480725
[TBL] [Abstract][Full Text] [Related]
20. [The effects of complete Freund's adjuvant on prevention of pancrentitis and diabetes mellitus in non-obese diabetic mice].
Niu X; Zhou Z; Jiang T; Su H
Zhonghua Nei Ke Za Zhi; 2002 Apr; 41(4):229-32. PubMed ID: 12133432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
